Mitsubishi Chemical to merge diagnostic units
This article was originally published in Clinica
Executive Summary
Mitsubishi Chemical (Tokyo, Japan) is merging three of its healthcare subsidiaries to form a single clinical diagnostics-focused organisation called Mitsubishi Kagaku Iatron, which will come into effect on July 1. The business is expected to generate sales of Y14.5bn ($120m) in the fiscal year ending March 31 2004. It will have assets worth around Y300bn and employ about 420 people. It comprises the businesses of Mitsubishi Kagaku Medical and Iatron Laboratories (diagnostic equipment and reagents in Japan and other markets), and Dia-Iatron, their 50:50 Japanese sales and marketing joint venture.